Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Violet Study: Ganaxolone in PCDH19-Related Epilepsy
NCT03865732Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- May 2019
- Primary completion
- Jan 2021
- Modality
- Allosteric Modulators
- Countries
- 5
01
Overview
A Phase 2 trial of ganaxolone in PCDH19-related epilepsy, sponsored by Marinus Pharmaceuticals. Started May 2019; status: completed.
02
Drugs
ganaxolone
03
Conditions
PCDH19-related epilepsy
Beyond the preview
Go deeper on NCT03865732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03865732.